Results 251 to 260 of about 19,583,123 (324)

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

A Novel Peak-Shape Aware Approach for Mass Alignment in Mass Spectrometry. [PDF]

open access: yesRapid Commun Mass Spectrom
Vanhemel T   +5 more
europepmc   +1 more source

Estimating COVID-19 incidence and prevalence using lateral flow tests in England and Scotland, 2023-2024. [PDF]

open access: yesNat Commun
Fyles M   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy